Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Modulating Neuroinflammation to Treat Neuropsychiatric Disorders.

Radtke FA, Chapman G, Hall J, Syed YA.

Biomed Res Int. 2017;2017:5071786. doi: 10.1155/2017/5071786. Epub 2017 Oct 18. Review.

2.

Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications.

Rosenblat JD, McIntyre RS.

Brain Sci. 2017 Oct 30;7(11). pii: E144. doi: 10.3390/brainsci7110144. Review.

3.
4.

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial.

Husain MI, Chaudhry IB, Hamirani MM, Minhas FA, Kazmi A, Hodsoll J, Haddad PM, Deakin JF, Husain N, Young AH.

Neuropsychiatr Dis Treat. 2016 Dec 19;13:1-8. doi: 10.2147/NDT.S115002. eCollection 2017.

5.

The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Fountoulakis KN, Yatham L, Grunze H, Vieta E, Young A, Blier P, Kasper S, Moeller HJ.

Int J Neuropsychopharmacol. 2017 Feb 1;20(2):121-179. doi: 10.1093/ijnp/pyw100.

6.

Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression.

Henter ID, de Sousa RT, Gold PW, Brunoni AR, Zarate CA Jr, Machado-Vieira R.

Expert Rev Clin Pharmacol. 2017 Feb;10(2):153-166. doi: 10.1080/17512433.2017.1253472. Epub 2017 Jan 16. Review.

7.

Neuroinflammation and cytokine abnormality in major depression: Cause or consequence in that illness?

Jeon SW, Kim YK.

World J Psychiatry. 2016 Sep 22;6(3):283-93. doi: 10.5498/wjp.v6.i3.283. eCollection 2016 Sep 22. Review.

8.

Inflammation in Depression and the Potential for Anti-Inflammatory Treatment.

Kohler O, Krogh J, Mors O, Benros ME.

Curr Neuropharmacol. 2016;14(7):732-42. Review.

9.

Role of Inflammation in Suicide: From Mechanisms to Treatment.

Brundin L, Bryleva EY, Thirtamara Rajamani K.

Neuropsychopharmacology. 2017 Jan;42(1):271-283. doi: 10.1038/npp.2016.116. Epub 2016 Jul 5.

PMID:
27377015
10.

Molecular Neurobiology and Promising New Treatment in Depression.

Jeon SW, Kim YK.

Int J Mol Sci. 2016 Mar 15;17(3):381. doi: 10.3390/ijms17030381.

11.

Microglial Cells as a Link between Cannabinoids and the Immune Hypothesis of Psychiatric Disorders.

Lisboa SF, Gomes FV, Guimaraes FS, Campos AC.

Front Neurol. 2016 Jan 28;7:5. doi: 10.3389/fneur.2016.00005. eCollection 2016. Review.

12.

Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers.

Muneer A.

Psychiatry Investig. 2016 Jan;13(1):18-33. doi: 10.4306/pi.2016.13.1.18. Epub 2015 Nov 20. Review.

13.

Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric Disorders.

Yui K, Imataka G, Nakamura H, Ohara N, Naito Y.

Curr Neuropharmacol. 2015;13(6):776-85. Review.

14.

A Randomized, Double-blind, Placebo-controlled Trial of Celecoxib Augmentation of Sertraline in Treatment of Drug-naive Depressed Women: A Pilot Study.

Majd M, Hashemian F, Hosseini SM, Vahdat Shariatpanahi M, Sharifi A.

Iran J Pharm Res. 2015 Summer;14(3):891-9.

15.

The Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar Disorder.

Kim HK, Chen W, Andreazza AC.

Neural Plast. 2015;2015:408136. doi: 10.1155/2015/408136. Epub 2015 May 13. Review.

16.

Elevated level of DNA damage and impaired repair of oxidative DNA damage in patients with recurrent depressive disorder.

Czarny P, Kwiatkowski D, Kacperska D, Kawczyńska D, Talarowska M, Orzechowska A, Bielecka-Kowalska A, Szemraj J, Gałecki P, Śliwiński T.

Med Sci Monit. 2015 Feb 6;21:412-8. doi: 10.12659/MSM.892317.

17.

Cytokines in bipolar disorder: paving the way for neuroprogression.

Barbosa IG, Bauer ME, Machado-Vieira R, Teixeira AL.

Neural Plast. 2014;2014:360481. doi: 10.1155/2014/360481. Epub 2014 Sep 9. Review.

18.

Biomarkers and clinical staging in psychiatry.

McGorry P, Keshavan M, Goldstone S, Amminger P, Allott K, Berk M, Lavoie S, Pantelis C, Yung A, Wood S, Hickie I.

World Psychiatry. 2014 Oct;13(3):211-23. doi: 10.1002/wps.20144.

19.

Effects of lithium on inflammation.

Nassar A, Azab AN.

ACS Chem Neurosci. 2014 Jun 18;5(6):451-8. doi: 10.1021/cn500038f. Epub 2014 May 6. Review.

20.

Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade.

Rapoport SI.

ACS Chem Neurosci. 2014 Jun 18;5(6):459-67. doi: 10.1021/cn500058v. Epub 2014 May 15. Review.

Supplemental Content

Support Center